1. Home
  2. CCNE vs DNA Comparison

CCNE vs DNA Comparison

Compare CCNE & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

N/A

Current Price

$33.38

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$12.95

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCNE
DNA
Founded
1865
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
835.7M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CCNE
DNA
Price
$33.38
$12.95
Analyst Decision
Buy
Sell
Analyst Count
6
3
Target Price
★ $38.00
$7.00
AVG Volume (30 Days)
106.7K
★ 3.0M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 2.26%
N/A
EPS Growth
4.18
★ 46.49
EPS
★ 1.79
N/A
Revenue
N/A
★ $170,155,000.00
Revenue This Year
$25.41
N/A
Revenue Next Year
$5.38
$13.37
P/E Ratio
$18.79
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$22.90
$5.37
52 Week High
$36.17
$18.22

Technical Indicators

Market Signals
Indicator
CCNE
DNA
Relative Strength Index (RSI) 42.49 62.50
Support Level $32.84 $6.86
Resistance Level $35.06 N/A
Average True Range (ATR) 0.60 1.75
MACD -0.03 0.13
Stochastic Oscillator 33.07 49.17

Price Performance

Historical Comparison
CCNE
DNA

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: